Most UK telehealth operators building a sexual health vertical eventually ask whether HIV PEP fits the model. It rarely does, not cleanly. PEP is an emergency intervention with a hard clinical deadline, and the thing telehealth is usually best at, removing the need to travel for a same-day appointment, is precisely what the 72-hour window punishes if a remote pathway adds any delay to that first dose.
What PEP is and why the clock matters
Post-exposure prophylaxis (PEP) is a short course of antiretroviral medication taken after a possible exposure to HIV, intended to stop the virus establishing infection. It is different from PrEP, which is taken before exposure on an ongoing basis to reduce risk in the first place; if your service already runs a PrEP pathway, do not assume the operational model transfers.
The defining feature of PEP is timing. UK clinical guidance treats the first 24 hours as the period of greatest effectiveness, and PEP is not normally started once 72 hours have passed since the exposure, because the evidence for benefit beyond that point is considered too weak to justify treatment. Every design decision in a PEP pathway follows from that window, not from the usual telehealth priorities of convenience or cost.
Where PEP is available in the UK today
PEP for sexual exposure, often referred to as PEPSE, is available free of charge through NHS sexual health (GUM) clinics during opening hours, and through hospital A&E departments outside them, since A&E is generally the only same-day option once sexual health clinics have closed.
- NHS sexual health (GUM) clinics, during opening hours
- Hospital accident and emergency departments, out of hours
- Selected community pharmacies under local commissioning arrangements
- NHS 111, for signposting to the nearest open service
None of this is telehealth-native. It is the existing NHS emergency access route, and it works today without a digital front end, which shapes what a viable private offer can realistically add.
Why remote-first telehealth struggles with true PEP
Standard telehealth dispensing assumes some tolerance for delay: a same-day or next-day consultation, a pharmacy dispensing window, then courier delivery. For most conditions that tolerance is fine. For PEP it strains the model, because a courier-dependent pathway that takes several hours to get medication into a patient's hands may still miss the period where PEP does the most good, even if it lands inside the 72-hour cut-off.
This is not a reason to avoid the vertical altogether. It is a reason to be precise about which part of the pathway telehealth actually improves. Remote assessment can often happen faster than a walk-in queue; remote dispensing to a patient's home generally cannot beat a staffed clinic handing over medication on the spot.
If a pathway cannot get medication to the patient faster than a walk-in clinic, do not build it as first-dose initiation; build it as fast triage and referral instead.
Where telehealth genuinely adds value: triage and routing
The strongest role for a telehealth operator here is not dispensing the first dose; it is getting the right patient to the right access point fast. A short remote consultation can assess exposure risk, rule out patients who do not need PEP, and route the rest to the nearest open clinic or A&E with the urgency already flagged, cutting the time a patient spends deciding what to do next.
Where an operator does hold a genuine same-day dispensing partnership, such as a local collection-point pharmacy rather than a courier, initiation dispensing becomes more defensible. The test is simple: can medication reach the patient inside a window that keeps pace with a walk-in clinic, not just inside 72 hours.
The regulatory and safeguarding layer
A PEP consultation surfaces the same safeguarding questions as any sexual health service, with less time to work through them. Non-consensual exposure, patients under 18, and repeat requests from the same patient all need a documented escalation path, not an assumption that the prescriber will catch it in the moment; see our guide to safeguarding in remote consultations for the underlying framework.
GPhC standards for remote prescribing and MHRA distance-selling requirements still apply in full; urgency is not an exemption. If a delay in your pathway means a patient misses the effective window, that is a duty of candour matter, not just an operational miss, and prescriber discretion applies to every initiation decision.
The 72-hour window is not a design constraint you can optimise around. It is the entire clinical model.
Continuation, adherence, and the 28-day course
Once PEP has been started, usually as a course lasting around a month, the clinical picture changes. Adherence support, managing side effects, and arranging follow-up HIV testing at appropriate intervals are all tasks that suit a remote model well, because the urgency has passed and the patient benefits more from convenient check-ins than from another in-person queue.
- Confirm the first dose was taken and log the course start date
- Schedule structured check-ins to monitor side effects and adherence
- Arrange follow-up HIV testing at the intervals set out in the initiating clinician's plan
- Provide a clear route back to urgent care if new symptoms appear
Building a PEP-aware pathway on PExpo
For clinics running or adding a sexual health vertical, the honest design choice is a hybrid: fast remote triage and referral for true emergency initiation, with a dispensing model built for continuation and adherence once the course has begun. PExpo's regulated dispensing layer supports same-day collection-point partnerships alongside standard delivery, so operators are not locked into a courier-only model for the part of the pathway where speed matters most.
See our guide on launching a UK sexual health telehealth service for the surrounding operational pieces, from escalation rotas to the referral relationships a PEP-aware pathway depends on.
HIV PEP is one of the few UK telehealth verticals where speed genuinely outranks convenience, and honest operators build for that rather than around it. Get the triage and referral layer right, then let a proper dispensing infrastructure carry the continuation phase; see our clinic model and brand model pages for how the two paths differ.
Frequently asked questions
What is the difference between PEP and PrEP?
PEP (post-exposure prophylaxis) is started after a possible HIV exposure has already happened, as an emergency course typically lasting around a month. PrEP (pre-exposure prophylaxis) is taken on an ongoing basis before any exposure, to reduce the risk of infection in the first place. The two are clinically and operationally distinct, and a service built around one does not automatically support the other. Prescriber discretion applies to both.
Can a UK telehealth service dispense PEP by courier?
In principle yes, but courier delivery has to be weighed against the clinical urgency of the 72-hour window, and ideally the first 24 hours. Most services find that same-day collection from a local dispensing partner, or referral to an NHS sexual health clinic or A&E, gets medication into a patient's hands faster than a standard delivery model. Courier dispensing tends to fit better for continuation of a course that has already started.
Is PEP free on the NHS?
PEP for sexual exposure is generally provided free of charge through NHS sexual health clinics and hospital A&E departments. Private telehealth services can offer a faster or more discreet route to assessment, but they are competing with an established, no-cost NHS pathway, which shapes what a viable private offer actually looks like.
